Evidence map›Paper›PMID 8246987›Full record

ArticleMolecular and cellular biology1993

Phosphatidylinositol (PI) 3-kinase and PI 4-kinase binding to the CD4-p56lck complex: the p56lck SH3 domain binds to PI 3-kinase but not PI 4-kinase.

K V Prasad, R Kapeller, O Janssen, H Repke, J S Duke-Cohan, L C Cantley, C E Rudd

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 1993. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
16.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 142 citations in OpenAlex.

  1. How the Discovery of the CD4/CD8-p56Frontiers in cell and developmental biology · 2021
    Review
  2. Article
  3. Review
  4. Article
  5. Fyn kinase regulates type II PtdIns 4-kinases in RBL 2H3 cells.Molecular and cellular biochemistry · 2014
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. CD28: a signalling perspective.The Biochemical journal · 1996
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

K V PrasadDivision of Tumor Immunology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115.
R Kapeller
O Janssen
H Repke
J S Duke-Cohan
L C Cantley
C E Rudd
Dana-Farber Cancer Institute · USHarvard University · US

Funding

The Role of PI3K in Growth RegulationR01GM041890 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI CANTLEY, LEWIS C. · 1990 to 2016
$4.1M
PHOSPHATDYLINOSITOL-3-P AND GROWTH REGULATIONR37GM041890 · NIGMS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI CANTLEY, LEWIS C. · 1999 to 2008
$3.8M
PHOSPHATIDYLINOSITOL KINASESR01GM036624 · NIGMS · TUFTS UNIVERSITY BOSTON · PI CANTLEY, LEWIS C. · 1986 to 2008
$2.9M
MOLECULAR ANALYSIS OF THE CD4/CD8--P56 LCK COMPLEXR01CA051887 · NCI · DANA-FARBER CANCER INSTITUTE · PI RUDD, CHRISTOPHER E. · 1990 to 2000
$253k
NCI NIH HHS NCI CA51887-02NIGMS NIH HHS GM 36624NIGMS NIH HHS GM 41890NIGMS NIH HHS R01 GM041890
6 · The paper itself

Abstract

CD4 serves as a receptor for major histocompatibility complex class II antigens and as a receptor for the human immunodeficiency virus type 1 (HIV-1) viral coat protein gp120. It is coupled to the protein-tyrosine kinase p56lck, an interaction necessary for an optimal response of certain T cells to antigen. In addition to the protein-tyrosine kinase domain, p56lck possesses Src homology 2 and 3 (SH2 and SH3) domains as well as a unique N-terminal region. The mechanism by which p56lck generates intracellular signals is unclear, although it has the potential to interact with various downstream molecules. One such downstream target is the lipid kinase phosphatidylinositol 3-kinase (PI 3-kinase), which has been found to bind to activated pp60src and receptor-tyrosine kinases. In this study, we verified that PI 3-kinase associates with the CD4:p56lck complex as judged by the presence of PI 3-phosphate generated from anti-CD4 immunoprecipitates and detected by high-pressure liquid chromatographic analysis. However, surprisingly, CD4-p56lck was also found to associate with another lipid kinase, phosphatidylinositol 4-kinase (PI 4-kinase). The level of associated PI 4-kinase was generally higher than PI 3-kinase activity. HIV-1 gp120 and antibody-mediated cross-linking induced a 5- to 10-fold increase in the level of CD4-associated PI 4- and PI 3-kinases. The use of glutathione S-transferase fusion proteins carrying Lck-SH2, Lck-SH3, and Lck-SH2/SH3 domains showed PI 3-kinase binding to the SH3 domain of p56lck, an interaction facilitated by the presence of an adjacent SH2 domain. PI 4-kinase bound to neither the SH2 nor the SH3 domain of p56lck. CD4-p56lck contributes PI 3- and PI 4-kinase to the activation process of T cells and may play a role in HIV-1-induced immune defects.

Indexed as

1-Phosphatidylinositol 4-KinaseAmino Acid SequenceBinding SitesCD4 AntigensCell LineHIV Envelope Protein gp120HumansLymphocyte Specific Protein Tyrosine Kinase p56(lck)Molecular Sequence DataPhosphatidylinositol 3-KinasesPhosphotransferases (Alcohol Group Acceptor)Protein BindingProtein-Tyrosine KinasesReceptors, HIVT-Lymphocytes1-Phosphatidylinositol 4-KinaseCD4 AntigensHIV Envelope Protein gp120Lymphocyte Specific Protein Tyrosine Kinase p56(lck)Phosphatidylinositol 3-KinasesPhosphotransferases (Alcohol Group Acceptor)Protein-Tyrosine KinasesReceptors, HIV

Identifiers

PMID8246987
PMCPMC364842
OpenAlexW2159103585

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.